nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADP-ribosylation of guanine nucleotide regulatory proteins
|
Ui, M. |
|
1990 |
183 |
1 |
p. 136-137 2 p. |
artikel |
2 |
Adverse immune reactions to a gold(I) drug are directed to gold(III), not gold(I). Detection by the popliteal lymphnode assay (PLNA)
|
Gleichmann, E. |
|
1990 |
183 |
1 |
p. 78-79 2 p. |
artikel |
3 |
Agonists, inverse agonists, and antagonists of benzodiazepine receptors
|
Haefely, W.E. |
|
1990 |
183 |
1 |
p. 38- 1 p. |
artikel |
4 |
Analysis of transmitter actions on dissociated retinal neurons
|
Kaneko, A. |
|
1990 |
183 |
1 |
p. 134-135 2 p. |
artikel |
5 |
A novel in vivo model of 5-HT1A function in the rat: 8-OH-DFAT-induced spontaneous tail-flicks
|
Millan, M.J. |
|
1990 |
183 |
1 |
p. 138- 1 p. |
artikel |
6 |
A novel protective mechanism: sensory nerve-mediated gastric mucosal vasodilatation
|
Holzer, P. |
|
1990 |
183 |
1 |
p. 128- 1 p. |
artikel |
7 |
Antimicrobial properties of quinolones
|
Shah, P.M. |
|
1990 |
183 |
1 |
p. 67- 1 p. |
artikel |
8 |
Audio-visual tools in teaching pharmacology
|
Brune, K. |
|
1990 |
183 |
1 |
p. 66- 1 p. |
artikel |
9 |
Author index
|
|
|
1990 |
183 |
1 |
p. i-lxviii nvt p. |
artikel |
10 |
Autoantibodies to cytochrome P-450 in drug-induced hepatitis in man
|
Beaune, P.H. |
|
1990 |
183 |
1 |
p. 80- 1 p. |
artikel |
11 |
Basic mechanisms and pre clinical assessment of antiepileptic drags in the soviet union
|
Chankvetadze, B. |
|
1990 |
183 |
1 |
p. 24- 1 p. |
artikel |
12 |
Behavioural approach to the study of the central nervous system
|
Iversen, S.D. |
|
1990 |
183 |
1 |
p. 50-51 2 p. |
artikel |
13 |
Bioassay, past and present
|
Burgen, A.S.V. |
|
1990 |
183 |
1 |
p. 49- 1 p. |
artikel |
14 |
Biogenic amine receptor regulation: rules and exceptions
|
Leysen, I.E. |
|
1990 |
183 |
1 |
p. 2- 1 p. |
artikel |
15 |
Botulinum ADP-ribosyltransferase C3, a pharmacological tool to examine function and transduction pathway of the rho gene products, the small molecular weight GTP-binding proteins
|
Narumiya, S. |
|
1990 |
183 |
1 |
p. 33- 1 p. |
artikel |
16 |
Brainstem endorphinergic mechanism in the regulation of blood pressure and heart rate
|
Kunos, G. |
|
1990 |
183 |
1 |
p. 7-8 2 p. |
artikel |
17 |
Calcium antagonists (CAs) and age-related neural disorders
|
Scriabine, A. |
|
1990 |
183 |
1 |
p. 58- 1 p. |
artikel |
18 |
Calcium antagonists in the therapy of migraine
|
Olesen, J. |
|
1990 |
183 |
1 |
p. 57-58 2 p. |
artikel |
19 |
Calcium regulation in resistance vessels
|
van Breemen, C. |
|
1990 |
183 |
1 |
p. 8-9 2 p. |
artikel |
20 |
Catechol-O-methyltransferase inhibitors: their role in the therapy of Parkinson's disease (PD)
|
Da Prada, M. |
|
1990 |
183 |
1 |
p. 4-5 2 p. |
artikel |
21 |
Cellular and subcellular localization of peripheral benzodiazepine receptors: Implications for a possible function in the control of intermediary metabolism
|
Anholt, R.R.H. |
|
1990 |
183 |
1 |
p. 145-146 2 p. |
artikel |
22 |
Changes in Ca2+ channels during ischaemia
|
Nayler, W.G. |
|
1990 |
183 |
1 |
p. 26- 1 p. |
artikel |
23 |
Circulating blood cells: a suitable tool to investigate human cardiovascular pharmacology?
|
Brodde, O.-E. |
|
1990 |
183 |
1 |
p. 152- 1 p. |
artikel |
24 |
Clinical efficacy and saftey of omeprazole
|
Olbe, L. |
|
1990 |
183 |
1 |
p. 22-23 2 p. |
artikel |
25 |
Clinical evidence for the role of serotonin (5HT) in anxiety ami depression
|
Wakelin, J.S. |
|
1990 |
183 |
1 |
p. 133- 1 p. |
artikel |
26 |
Clinical pharmacology of the selective enkephalinase inhibitors SCH 32615/34826
|
Chipkin, R.E. |
|
1990 |
183 |
1 |
p. 78- 1 p. |
artikel |
27 |
Clinical trials of potassium channel openers
|
Carlsen, J.E. |
|
1990 |
183 |
1 |
p. 70-71 2 p. |
artikel |
28 |
Conditioned drug effects
|
Goudie, A.J. |
|
1990 |
183 |
1 |
p. 98- 1 p. |
artikel |
29 |
Contraceptive vaccine development
|
Aitken, R.J. |
|
1990 |
183 |
1 |
p. 13- 1 p. |
artikel |
30 |
Control of renal blood flow by circulating and local hormones
|
Hofbauer, K.G. |
|
1990 |
183 |
1 |
p. 44- 1 p. |
artikel |
31 |
Control of the peripheral resistance: which vessels?
|
Mulvany, M.J. |
|
1990 |
183 |
1 |
p. 64- 1 p. |
artikel |
32 |
Conversion of somatostatin to an opioid peptide: design using a conformational template and topographical constraints
|
Hruby, V.J. |
|
1990 |
183 |
1 |
p. 54-55 2 p. |
artikel |
33 |
Correlation between biochemical and biological properties of thrombolytic agents
|
Collen, D. |
|
1990 |
183 |
1 |
p. 123- 1 p. |
artikel |
34 |
Corticosteroid receptor function in the brain
|
De Kloet, E.R. |
|
1990 |
183 |
1 |
p. 125- 1 p. |
artikel |
35 |
Criteria for drug registration
|
Griffin, J.P. |
|
1990 |
183 |
1 |
p. 18-19 2 p. |
artikel |
36 |
Cytokines: synthesis and release by epidermal cells under conditions of inflammation
|
Luger, T.A. |
|
1990 |
183 |
1 |
p. 130- 1 p. |
artikel |
37 |
Debate: Nootropics yes or no!
|
Kanowski, S. |
|
1990 |
183 |
1 |
p. 84- 1 p. |
artikel |
38 |
Differential effects of intracerebroventricular μ and δ selective opioids on small and large intestinal motility and transit in the rat
|
Burks, T.F. |
|
1990 |
183 |
1 |
p. 139-140 2 p. |
artikel |
39 |
Direct comparisons of streptokinase versus anistreplase
|
Anderson, J.L. |
|
1990 |
183 |
1 |
p. 123-124 2 p. |
artikel |
40 |
Discovery by serendipity
|
Lembeck, F. |
|
1990 |
183 |
1 |
p. 86- 1 p. |
artikel |
41 |
Distribution and function of enkephalinase: implications for inhibitor therapy
|
Erdös, E.G. |
|
1990 |
183 |
1 |
p. 77- 1 p. |
artikel |
42 |
3D-QSAR: known and unknown receptors
|
Marshall, G.R. |
|
1990 |
183 |
1 |
p. 15- 1 p. |
artikel |
43 |
Drag targeting by site-specific chemical drug delivery systems
|
Bodor, N. |
|
1990 |
183 |
1 |
p. 119-120 2 p. |
artikel |
44 |
Drugs as positive reinforcing and punishing stimuli
|
Hoffmeister, F. |
|
1990 |
183 |
1 |
p. 97- 1 p. |
artikel |
45 |
Drug transport related effects in the kidney. The example of diuretics
|
Odlind, B.G. |
|
1990 |
183 |
1 |
p. 102-103 2 p. |
artikel |
46 |
Early testing off experimental antiepileptic drags in humans
|
Binnie, C.D. |
|
1990 |
183 |
1 |
p. 23- 1 p. |
artikel |
47 |
Editorial Board
|
|
|
1990 |
183 |
1 |
p. IFC- 1 p. |
artikel |
48 |
Effects of calcium-antagonists on cerebral ischemia
|
Hartmann, A. |
|
1990 |
183 |
1 |
p. 57- 1 p. |
artikel |
49 |
Endogeneous brain opioid peptides and blood pressure regulation
|
de Jong, W. |
|
1990 |
183 |
1 |
p. 6- 1 p. |
artikel |
50 |
Endogenous factors that selectively modify drug metabolism
|
Kato, R. |
|
1990 |
183 |
1 |
p. 41-42 2 p. |
artikel |
51 |
Endothelium-dependent contractile modulation in cerebral artery
|
Fujiwara, M. |
|
1990 |
183 |
1 |
p. 108-109 2 p. |
artikel |
52 |
Endothelium-derived relaxing and contracting factor: pathological and therapeutic implications
|
Vanhoutte, P.M. |
|
1990 |
183 |
1 |
p. 109-110 2 p. |
artikel |
53 |
Enkephalinase inhibitors: potential therapeutic applications in gastroenterology and the cardiovascular field
|
Schwartz, J.-C. |
|
1990 |
183 |
1 |
p. 76-77 2 p. |
artikel |
54 |
Enorphins and drug seeking behaviour
|
van Ree, J.M. |
|
1990 |
183 |
1 |
p. 39- 1 p. |
artikel |
55 |
Excitatory amino acid receptors and channels
|
Garthwaite, J. |
|
1990 |
183 |
1 |
p. 150- 1 p. |
artikel |
56 |
Factors determining the kinetics of percutaneous absorption
|
Guy, R.H. |
|
1990 |
183 |
1 |
p. 129-130 2 p. |
artikel |
57 |
Fatty acid ω-hydroxylases
|
Ortiz de Montellano, P.R. |
|
1990 |
183 |
1 |
p. 95- 1 p. |
artikel |
58 |
Features of the potassium channel in vascular smooth muscle cells and their modulating drugs
|
Kuriyama, H. |
|
1990 |
183 |
1 |
p. 69- 1 p. |
artikel |
59 |
From endothelium-derived relaxing factor to nitric oxide. The role of vascular endothelium in the control of blood flow
|
Moncada, S. |
|
1990 |
183 |
1 |
p. 109- 1 p. |
artikel |
60 |
Functional aspects of peripheral benzodiazepine receptors
|
Gavish, M. |
|
1990 |
183 |
1 |
p. 144- 1 p. |
artikel |
61 |
Functional pharmacologic receptor classification: are the problems real or theoretical?
|
Bond, R.A. |
|
1990 |
183 |
1 |
p. 82- 1 p. |
artikel |
62 |
Functional plasticity after lesion of aminergic pathways
|
Le Moal, M. |
|
1990 |
183 |
1 |
p. 31-32 2 p. |
artikel |
63 |
Future strategies in the treatment of Parkinson's disease
|
Cools, A.R. |
|
1990 |
183 |
1 |
p. 5- 1 p. |
artikel |
64 |
GABAA receptor regulation after repeated administration of negative and positive modulators
|
Biggio, G. |
|
1990 |
183 |
1 |
p. 3- 1 p. |
artikel |
65 |
Genetic and environmental causes of variability in drug response
|
Vesell, E.S. |
|
1990 |
183 |
1 |
p. 111- 1 p. |
artikel |
66 |
G-proteins and the regulation of effector function
|
Iyengar, R. |
|
1990 |
183 |
1 |
p. 121-122 2 p. |
artikel |
67 |
Growth factors and manipulation of animal growth
|
Holder, A.T. |
|
1990 |
183 |
1 |
p. 12- 1 p. |
artikel |
68 |
Growth factors and their physiological implications for development
|
Hill, D.J. |
|
1990 |
183 |
1 |
p. 11-12 2 p. |
artikel |
69 |
Homeopathy placebo therapy?
|
Ariëns, E.J. |
|
1990 |
183 |
1 |
p. 153- 1 p. |
artikel |
70 |
Immunotoxins for clinical applications
|
Baldwin, R.W. |
|
1990 |
183 |
1 |
p. 46-47 2 p. |
artikel |
71 |
Influence of macromolecular synthesis and memory consolidation
|
Matthies, H. |
|
1990 |
183 |
1 |
p. 71- 1 p. |
artikel |
72 |
Inhibition by interferon (IFN) of the development of hepatic and splenic metastases in mice: role of host mechanisms
|
Gresser, I. |
|
1990 |
183 |
1 |
p. 113- 1 p. |
artikel |
73 |
Inhibition of sympathetic outflow by methionine enkephalin as a mechanism of central opioid action
|
Rhee, H.M. |
|
1990 |
183 |
1 |
p. 7- 1 p. |
artikel |
74 |
Inhibitory monoclonal antibodies and cDNA expression for the characterization of cytochrome P450 function
|
Gelboin, H.V. |
|
1990 |
183 |
1 |
p. 42- 1 p. |
artikel |
75 |
Inositol lipids and calcium signalling
|
Berridge, M.J. |
|
1990 |
183 |
1 |
p. 84-85 2 p. |
artikel |
76 |
Interactions between PAF, cytokines and FcϵRII/CD23 receptors in the control of allergic and inflammatory processes
|
Braquet, P. |
|
1990 |
183 |
1 |
p. 75-76 2 p. |
artikel |
77 |
Intravital microscopy and microcirculation: pharmacological applications
|
De Clerck, F. |
|
1990 |
183 |
1 |
p. 65- 1 p. |
artikel |
78 |
In vitro forecasting of genetic and environmental effects on drug oxidation
|
Dayer, P. |
|
1990 |
183 |
1 |
p. 59-60 2 p. |
artikel |
79 |
Is homoeopathy a placebo therapy?
|
Kennedy, C.O. |
|
1990 |
183 |
1 |
p. 154- 1 p. |
artikel |
80 |
Isolated perfused porcine skin flap model
|
Riviere, J.E. |
|
1990 |
183 |
1 |
p. 129- 1 p. |
artikel |
81 |
Is the gastric lipoxygenase system A target protective drugs?
|
Peskar, B.M. |
|
1990 |
183 |
1 |
p. 126-127 2 p. |
artikel |
82 |
Limitations and possibilities of magnetic resonance in drag imaging and spectroscopy
|
Seelig, J. |
|
1990 |
183 |
1 |
p. 81-82 2 p. |
artikel |
83 |
Linear and nonlinear system analysis approaches applied to analyze kinetic and mechanistic problems in pharmacology
|
Veng-Pedersen, P. |
|
1990 |
183 |
1 |
p. 31- 1 p. |
artikel |
84 |
Localization and function of components of the β-adrenergic system in human and blood vessels
|
Summers, R.J. |
|
1990 |
183 |
1 |
p. 151- 1 p. |
artikel |
85 |
Malaria vaccine development
|
Martinez, L. |
|
1990 |
183 |
1 |
p. 63- 1 p. |
artikel |
86 |
Mechanism of acid secretion by the parietal cell
|
Sewing, K.-Fr. |
|
1990 |
183 |
1 |
p. 21- 1 p. |
artikel |
87 |
Mechanisms of drug resistance in cancer therapy
|
Gottesman, M.M. |
|
1990 |
183 |
1 |
p. 17-18 2 p. |
artikel |
88 |
Melecular biology, the new biology and pharmacology
|
Dollery, C.T. |
|
1990 |
183 |
1 |
p. 16- 1 p. |
artikel |
89 |
Metabolism and pharmacokinetics of biological response modifiers (BRMS)
|
Bocci, V. |
|
1990 |
183 |
1 |
p. 112-113 2 p. |
artikel |
90 |
Micropharmacology of spinal synaptic terminals
|
Curtis, D.R. |
|
1990 |
183 |
1 |
p. 86-87 2 p. |
artikel |
91 |
Mode of action of omeprazole and its effect on acid secretion
|
Wallmark, E. |
|
1990 |
183 |
1 |
p. 21-22 2 p. |
artikel |
92 |
Modulatory effect of somatostatin on muscarinic mechanisms in brain
|
Miyoshi, R. |
|
1990 |
183 |
1 |
p. 56- 1 p. |
artikel |
93 |
Molecular biology of vascular hypertrophy
|
Campbell, J.H. |
|
1990 |
183 |
1 |
p. 90- 1 p. |
artikel |
94 |
Molecular mechanisms of variation in drug response
|
Meyer, U.A. |
|
1990 |
183 |
1 |
p. 111-112 2 p. |
artikel |
95 |
Molecular structure and dynamics of G protein coupled receptors and their ligands
|
Dahl, S.G. |
|
1990 |
183 |
1 |
p. 14- 1 p. |
artikel |
96 |
Muscarinic acetylcholine receptor subtypes: molecular distinction and selective effector coupling
|
Fukuda, K. |
|
1990 |
183 |
1 |
p. 105- 1 p. |
artikel |
97 |
Muscarinic receptor subtypes
|
Mutschler, E. |
|
1990 |
183 |
1 |
p. 117-119 3 p. |
artikel |
98 |
Narcotics
|
Woods, J.H. |
|
1990 |
183 |
1 |
p. 37-38 2 p. |
artikel |
99 |
Neural receptors and psychotropic drugs
|
Snyder, S.H. |
|
1990 |
183 |
1 |
p. 19-20 2 p. |
artikel |
100 |
Neurobehavirol indices of recovery from unilateral sensory deprivation and lesion of the nigro-striatal system
|
Huston, J.P. |
|
1990 |
183 |
1 |
p. 32- 1 p. |
artikel |
101 |
Neurochemical aspects of opioid addiction
|
Herz, A. |
|
1990 |
183 |
1 |
p. 140- 1 p. |
artikel |
102 |
Neuroendocrine and sympathetic responses to interleukin-1 in rats
|
Berkenbosch, F. |
|
1990 |
183 |
1 |
p. 35- 1 p. |
artikel |
103 |
Neuroleptic/dopamine receptors: search for new g-linked receptors
|
Seeman, P. |
|
1990 |
183 |
1 |
p. 106-107 2 p. |
artikel |
104 |
Neuroleptics in modern psychiatry
|
Vinar⌣, O. |
|
1990 |
183 |
1 |
p. 107-108 2 p. |
artikel |
105 |
Neuropeptide metabolism in airways by neutral endopeptidase
|
Nadel, J.A. |
|
1990 |
183 |
1 |
p. 93- 1 p. |
artikel |
106 |
Neuropeptides and airway functions
|
Widdicombe, J.G. |
|
1990 |
183 |
1 |
p. 92- 1 p. |
artikel |
107 |
Neuropeptides and asthma
|
Barnes, P.J. |
|
1990 |
183 |
1 |
p. 94- 1 p. |
artikel |
108 |
Neurotransmission in afferent neurons
|
Lembeck, F. |
|
1990 |
183 |
1 |
p. 133-134 2 p. |
artikel |
109 |
Neutrophil-mediated metabolism of autoimmunity inducing drugs
|
Rubin, R.L. |
|
1990 |
183 |
1 |
p. 79-80 2 p. |
artikel |
110 |
New contraceptive delivery systems
|
Vemer, H.M. |
|
1990 |
183 |
1 |
p. 13-14 2 p. |
artikel |
111 |
Nitric oxide, a mediator of cellular communication
|
Moncada, S. |
|
1990 |
183 |
1 |
p. 158-159 2 p. |
artikel |
112 |
Octreotide: drug development of a constrained somatostatin analogue
|
Bauer, W. |
|
1990 |
183 |
1 |
p. 55- 1 p. |
artikel |
113 |
Overview of existing and future anti-ischaemic drugs
|
Massingham, R. |
|
1990 |
183 |
1 |
p. 27- 1 p. |
artikel |
114 |
Oxidative stress: reactive oxygen species in toxicology and pharmacology
|
Sies, H. |
|
1990 |
183 |
1 |
p. 49-50 2 p. |
artikel |
115 |
PAF and allergy
|
Vargaftig, B.B. |
|
1990 |
183 |
1 |
p. 73-74 2 p. |
artikel |
116 |
PAF and PAF-antagonists in animal models of bronchial hyperreactivity
|
Nijkamp, F.P. |
|
1990 |
183 |
1 |
p. 74-75 2 p. |
artikel |
117 |
Parameters for assessment of biological responses to IFNs
|
Huber, C.H. |
|
1990 |
183 |
1 |
p. 114- 1 p. |
artikel |
118 |
Patient-oriented problem solving: a fresh tasting of old wine
|
Riker, W.K. |
|
1990 |
183 |
1 |
p. 65-66 2 p. |
artikel |
119 |
Peptide receptors of the blood-brain barrier and the consequences for transport mechanisms
|
Ermisch, A. |
|
1990 |
183 |
1 |
p. 115- 1 p. |
artikel |
120 |
Peptides and memory formation
|
Telegdy, G. |
|
1990 |
183 |
1 |
p. 72-73 2 p. |
artikel |
121 |
Peptide toxins from venoms as pharmacological agents: conotoxins as examples
|
Olivera, B.M. |
|
1990 |
183 |
1 |
p. 34- 1 p. |
artikel |
122 |
Pharmaceutical and medical criteria for the selection off essential drug
|
Merkus, F.W.H.M. |
|
1990 |
183 |
1 |
p. 99-100 2 p. |
artikel |
123 |
Pharmaco-epidemiology of anti-inflammatory drugs
|
Urquhart, J. |
|
1990 |
183 |
1 |
p. 52-53 2 p. |
artikel |
124 |
Pharmacokinetics of quinolones
|
Bergan, T. |
|
1990 |
183 |
1 |
p. 68- 1 p. |
artikel |
125 |
Pharmacological actions of potassium-channel openers
|
Weston, A.H. |
|
1990 |
183 |
1 |
p. 70- 1 p. |
artikel |
126 |
Pharmacological manipulation of vasoactive mediators in gastric damage and protection
|
Whittle, B.J.R. |
|
1990 |
183 |
1 |
p. 127-128 2 p. |
artikel |
127 |
Pharmacology and the new biology
|
van Zwieten, P.A. |
|
1990 |
183 |
1 |
p. 16-17 2 p. |
artikel |
128 |
Pharmacology of cotransmissiom
|
Lundberg, J.M. |
|
1990 |
183 |
1 |
p. 156-157 2 p. |
artikel |
129 |
Pharmacology of depression and anxiety
|
Segawa, T. |
|
1990 |
183 |
1 |
p. 132-133 2 p. |
artikel |
130 |
Pharmacology of endothelin
|
Masaki, T. |
|
1990 |
183 |
1 |
p. 120-121 2 p. |
artikel |
131 |
Pharmacology of ion channels: past, present and future
|
Narahashi, T. |
|
1990 |
183 |
1 |
p. 149- 1 p. |
artikel |
132 |
Pharmacotherapy of Alzheimer's disease: present opportunities and future possibilities
|
Reisberg, B. |
|
1990 |
183 |
1 |
p. 83- 1 p. |
artikel |
133 |
Plants as sources for agents affecting cellular Ca++ regulation
|
Pang, P.K.T. |
|
1990 |
183 |
1 |
p. 28- 1 p. |
artikel |
134 |
Potential-sensitivity of calcium channels in microvessels: functional implications
|
Mulvany, M.J. |
|
1990 |
183 |
1 |
p. 10-11 2 p. |
artikel |
135 |
Preface
|
|
|
1990 |
183 |
1 |
p. V- 1 p. |
artikel |
136 |
Present state of the control of schistosomiasis
|
Bergquist, N.R. |
|
1990 |
183 |
1 |
p. 47- 1 p. |
artikel |
137 |
Protein transport through cultured brain microvessel endothelial cells, a model of the blood-brain barrier
|
Borchardt, R.T. |
|
1990 |
183 |
1 |
p. 114- 1 p. |
artikel |
138 |
Psychological factors related to variability in drug response
|
Netter, P.S. |
|
1990 |
183 |
1 |
p. 110- 1 p. |
artikel |
139 |
Psychotropic drug effects and the peripheral benzodiazepine receptors
|
Saano, V. |
|
1990 |
183 |
1 |
p. 144-145 2 p. |
artikel |
140 |
Quantitative imaging techniques in pharmacological in vivo drug studies
|
Hantraye, Ph. |
|
1990 |
183 |
1 |
p. 81- 1 p. |
artikel |
141 |
Rationale versus serendipity in pharmacology; the case for rationale
|
Black, J.W. |
|
1990 |
183 |
1 |
p. 85- 1 p. |
artikel |
142 |
Recent advances in the chemotherapy of malaria
|
Warhurst, D.C. |
|
1990 |
183 |
1 |
p. 62- 1 p. |
artikel |
143 |
Recent studies on Chinese meteria medica for calcium antagonists
|
Zhengang, W. |
|
1990 |
183 |
1 |
p. 29-30 2 p. |
artikel |
144 |
Receptor-mediated gene delivery and expression in hepatocytes
|
Wu, G.Y. |
|
1990 |
183 |
1 |
p. 147- 1 p. |
artikel |
145 |
Receptor modulation and cAMP dependent phosphorylation system after repeated antidepressant administration
|
Racagni, G. |
|
1990 |
183 |
1 |
p. 1- 1 p. |
artikel |
146 |
Reflex cardiovascular control in health and cardiovascular disease
|
Mancia, G. |
|
1990 |
183 |
1 |
p. 117- 1 p. |
artikel |
147 |
Renal drug transport and disposition
|
De Broe, M.E. |
|
1990 |
183 |
1 |
p. 101-102 2 p. |
artikel |
148 |
Renal effects of thromboxane synthesis inhibitors and receptor antagonists
|
Patrono, C. |
|
1990 |
183 |
1 |
p. 143- 1 p. |
artikel |
149 |
Renal vasodilation: pathophysiological and therapeutic implications
|
Hall, J.E. |
|
1990 |
183 |
1 |
p. 45- 1 p. |
artikel |
150 |
Role of guanine nucleotide-binding proteins in regulation of adenylyl cyclase
|
Jakobs, K.H. |
|
1990 |
183 |
1 |
p. 137- 1 p. |
artikel |
151 |
Role of herbal medicine in geriatrics
|
Orimo, H. |
|
1990 |
183 |
1 |
p. 29- 1 p. |
artikel |
152 |
Role played by interleukin-1 (IL-1) in the regulation of nerve growth factor (NGF) synthesis under physiological and pathophysiological conditions
|
Thoeneu, H. |
|
1990 |
183 |
1 |
p. 36-37 2 p. |
artikel |
153 |
Scientific and ethical reasons for the use of alternative methods in new drug development
|
Balls, M. |
|
1990 |
183 |
1 |
p. 130-131 2 p. |
artikel |
154 |
Selective inhibition of glucuronidation and sulfation in vitro and in vivo
|
Mulder, G.J. |
|
1990 |
183 |
1 |
p. 43- 1 p. |
artikel |
155 |
Selective killing of malignant cells fey antibody-ricin conjugates (‘immunotoxins’)
|
Thorpe, P. |
|
1990 |
183 |
1 |
p. 146-147 2 p. |
artikel |
156 |
Selective renal vasodilation: pharmacological approaches
|
Struyker Boudier, H.A.J. |
|
1990 |
183 |
1 |
p. 46- 1 p. |
artikel |
157 |
Sensitivity of the mesenteric vascular bed in three rat models of hypertension
|
Fleming, W.W. |
|
1990 |
183 |
1 |
p. 91- 1 p. |
artikel |
158 |
Sites of renal prostaglandin production
|
Herman, A.G. |
|
1990 |
183 |
1 |
p. 141-142 2 p. |
artikel |
159 |
Small versus large cardiovascular trials
|
Sleight, P. |
|
1990 |
183 |
1 |
p. 155-156 2 p. |
artikel |
160 |
Small versus large cardiovascular trials
|
Maseri, A. |
|
1990 |
183 |
1 |
p. 155- 1 p. |
artikel |
161 |
Steroid and thyroid hormones and neural plasticity
|
McEwen, B.S. |
|
1990 |
183 |
1 |
p. 124- 1 p. |
artikel |
162 |
Stimulus properties of drugs
|
Järbe, T.U.C. |
|
1990 |
183 |
1 |
p. 96-97 2 p. |
artikel |
163 |
Structure and function of neurotransmitter receptors and ionic channels
|
Numa, S. |
|
1990 |
183 |
1 |
p. 157-158 2 p. |
artikel |
164 |
Structure/function and new members of the catecholamine receptor family
|
Caron, M.G. |
|
1990 |
183 |
1 |
p. 104- 1 p. |
artikel |
165 |
Study designs in drug epidemiology
|
McNeil, J.J. |
|
1990 |
183 |
1 |
p. 116- 1 p. |
artikel |
166 |
Synaptic plasticity, NMDA receptors and learning
|
Morris, R.G.M. |
|
1990 |
183 |
1 |
p. 72- 1 p. |
artikel |
167 |
Syntheis and effects of leukotrienes and other lipoxgenase products of arachidonic acid in the kidney
|
Ardaillou, R. |
|
1990 |
183 |
1 |
p. 142- 1 p. |
artikel |
168 |
Synthetic interleukin 1 fragments with agonist activity
|
Boraschi, D. |
|
1990 |
183 |
1 |
p. 35-36 2 p. |
artikel |
169 |
System dynamics and chaos theory in drug action
|
van Rossum, J.M. |
|
1990 |
183 |
1 |
p. 30- 1 p. |
artikel |
170 |
Targeting of drugs by endogenous transport vehicles
|
van Berkel, Th.J.C. |
|
1990 |
183 |
1 |
p. 148- 1 p. |
artikel |
171 |
The adrenergic receptors: structure/function and regulation
|
Lefkowitz, R.J. |
|
1990 |
183 |
1 |
p. 53- 1 p. |
artikel |
172 |
The arthritic rat as a model of clinical pain?
|
Besson, J.M. |
|
1990 |
183 |
1 |
p. 100-101 2 p. |
artikel |
173 |
The changing role of drugs in malaria control
|
Wernsdorfer, W.H. |
|
1990 |
183 |
1 |
p. 61-62 2 p. |
artikel |
174 |
The detection of adverse drug reactions in the elderly
|
Bulpitt, C.J. |
|
1990 |
183 |
1 |
p. 115-116 2 p. |
artikel |
175 |
The essential drug concept-ten years on
|
Dunne, J.F. |
|
1990 |
183 |
1 |
p. 99- 1 p. |
artikel |
176 |
The experimental deign and analysis of in vivo studies of polymorphic drug oxidation
|
Tucker, G.T. |
|
1990 |
183 |
1 |
p. 60-61 2 p. |
artikel |
177 |
The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration
|
Riederer, P. |
|
1990 |
183 |
1 |
p. 3-4 2 p. |
artikel |
178 |
The molecular pharmacology of GABAA/benzodiazepine receptors
|
Seeburg, P.H. |
|
1990 |
183 |
1 |
p. 104-105 2 p. |
artikel |
179 |
The need for animal models of chronic pain: the point of view of a clinician
|
Gybels, J. |
|
1990 |
183 |
1 |
p. 100- 1 p. |
artikel |
180 |
The pharmacokinetics and clinical importance of polymorphic drug oxidation
|
Wilkinson, G.R. |
|
1990 |
183 |
1 |
p. 59- 1 p. |
artikel |
181 |
The role of lipid metabolites in calcium mobilisation during ischaemia: potential new therapies
|
Spedding, M. |
|
1990 |
183 |
1 |
p. 25- 1 p. |
artikel |
182 |
The use of cultured animal and human hepatocytes in studies of drug metabolism and hepatotoxicity
|
Guillouzo, A. |
|
1990 |
183 |
1 |
p. 131-132 2 p. |
artikel |
183 |
Thromboxane and prostacyclin synthases
|
Ullrich, V. |
|
1990 |
183 |
1 |
p. 95-96 2 p. |
artikel |
184 |
Treatment of mild heart failure: atrial natriuretic peptide and angiotensin converting enzyme inhibition
|
Riegger, A.J.G. |
|
1990 |
183 |
1 |
p. 41- 1 p. |
artikel |
185 |
Treatment of schistosomiasis-scene setting
|
Vanden Bossche, H. |
|
1990 |
183 |
1 |
p. 48- 1 p. |
artikel |
186 |
Trends in the treatment of mild heart failure: new positive inotropic agents
|
Ravens, U. |
|
1990 |
183 |
1 |
p. 40- 1 p. |
artikel |
187 |
Typical and atypical neuroleptics; similarity and dissimilarity features
|
Rayevsky, K.S. |
|
1990 |
183 |
1 |
p. 105-106 2 p. |
artikel |
188 |
Vascular hypertrophy caused by sympathetic denervation
|
Osswald, W. |
|
1990 |
183 |
1 |
p. 89- 1 p. |
artikel |
189 |
Vascular smooth muscle calcium channels
|
Benham, C.D. |
|
1990 |
183 |
1 |
p. 9-10 2 p. |
artikel |
190 |
Vasopressin and oxytocin receptors: agonists and antagonists
|
Jard, S. |
|
1990 |
183 |
1 |
p. 87-88 2 p. |
artikel |